First amyloid β1‐42 certified reference material for re‐calibrating commercial immunoassays. Alzheimer’s Association; doi.org/10.1002/alz.12145. Boulo,S., Kuhlmann,J., Andreasson,U., Venkataraman,I., Herbst,V., Rutz,S., Manuilova,E., Vandijck,M., Dekeyser,F., Bjerke,M., Pannee,J., Charoud-Got,J., Auclair,G., Mazoua,S., Pinski,G., Trapmann,S., Schimmel,H., Emons, H., Quaglia,M., Portelius,E., Korecka, M., Shaw,L., Lame,M., Chambers, E., Vanderstichele,H., Stoops, E., Leinenbach, A., Bittner,T., Jenkins,R., Kostanjevecki,V., Lewczuk,P., Gobom,J., Zetterberg,H., Zegers,I., Blennow,K. (2020)
Alzheimer’s Association; doi.org/10.1002/alz.12145.
